Bytey-MV 80.2 Tablet SR
Marketer
Arrient Healthcare Pvt Ltd
Salt Composition
Voglibose (0.2mg) + Metformin (500mg) + Gliclazide (80mg)
Overview Bytey-MV 80.2 Tablet SR
Diabetol-Duo 80.2 Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation manages type 2 diabetes in adults by regulating blood glucose. Diabetol-Duo 80.2 ER should be administered with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your healthcare provider; lifestyle choices significantly impact diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar). Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat them. Maintain regular meals and carry a quick-acting glucose source, such as candy or juice. Alcohol consumption elevates hypoglycemia risk and should be avoided. Other possible side effects include altered taste perception, nausea, vomiting, diarrhea, abdominal discomfort, headache, edema, blurred vision, and bone fractures. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their doctor before starting treatment. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.
Primary Ingredients of Bytey-MV 80.2 Tablet SR
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Bytey-MV 80.2 Tablet SR
Managing type 2 diabetes
Major Benefits of Bytey-MV 80.2 Tablet SR:
Consume Bytey-MV 80.2 Tablet SR precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid crushing, chewing, or fracturing it. Administer with a meal.
Common Side effects of Bytey-MV 80.2 Tablet SR:
- Nausea
- Hypoglycemia (low blood glucose level)
- Abdominal pain
- Constipation
How to use Bytey-MV 80.2 Tablet SR:
Consume Bytey-MV 80.2 Tablet SR precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Take with food.
How Bytey-MV 80.2 Tablet SR works:
The extended-release tablet, Bytey-MV 80.2, contains a triple-drug formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Bytey-MV 80.2 Tablet SR is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Bytey-MV 80.2 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCAUTION
The extended-release Bytey-MV 80.2 tablet necessitates careful consideration when breastfeeding. Mothers should discontinue breastfeeding throughout their treatment course and until the medication is fully cleared from their system.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when administering Bytey-MV 80.2 Tablet SR to individuals with impaired kidney function; dosage modification may be necessary. Physician consultation is advised. Bytey-MV 80.2 Tablet SR is contraindicated in patients exhibiting severe renal impairment. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Bytey-MV 80.2 Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; use is contraindicated in patients with severe liver disease.
What if you forget to take Bytey-MV 80.2 Tablet SR :
NA
Facts to Know About Bytey-MV 80.2 Tablet SR
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Medication for diabetes |
3,018 People bought this recently